You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Production of High Specific Activity Lutetium-177

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): A separation method will be tested and evaluated to determine the feasibility of providing no carrier added lutetium-177 (Lu-177) for use in radiotherapeutic applications. An indirect method will be used to produce Lu-177 (neutron capture followed by decay). Separation of the Lu-177 from the target material will enable us to provide carrier-free Lu-177 suita ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Novel Nanostructured Calcium Phosphate for Gene Delivery to Bone

    SBC: Angstrom Medica, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Osteoporosis is a major and growing health care problem that responds inadequately to standard pharmacologic therapy. Because of its low bone mineral density, osteoporotic bone is mechanically weak and fractures more easily than normal bone. Moreover, fracture repair is compromised in osteoporotic patients. The work described in this Phase I STTR proposal aims ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Design of an Automated Psoriasis Treatment System

    SBC: Boston Array Technologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Up to 3 percent of populations worldwide have psoriasis. A large number of the patients with psoriasis can be treated using UV light exposure. We propose to employ a light modulating microchip based on recent Micro Electro Mechanical Systems (MEMS) technological developments to build an Automated Psoriasis Treatment System. The overall goal of Phase I a ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Use of Self-Assembled Crystals in Cyanide Detection

    SBC: CHEMMOTIF, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): ChemMotif, Inc. is developing a range of sophisticated test strips that are reliable and sufficiently sensitive to be useful in public health, environmental, and homeland security applications. The objective of this proposal is the development of an improved analytical test strip for the determination of cyanide in water at or below EPA actionable levels (0. ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Oral Therapeutic for Beta-Thalassemia

    SBC: Gene Regulation Laboratories            Topic: N/A

    DESCRIPTION (provided by applicant): The beta thalassemia syndromes are prevalent genetic disorders caused by molecular mutations affecting the genes for adult hemoglobin and cause early mortality from complications of blood transfusions. These conditions can be ameliorated by reactivating production of fetal hemoglobin (Hb F) in the patients' blood. Pharmacologic re-induction of HbF has been achi ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  6. Transgenic Goats Produced by Germ Cell Transplantation

    SBC: GTC BIOTHERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this proposal is to produce transgenic goats by manipulation of the male germ line through male germ cell transfection and transplantation. The goats will carry the gene for human growth hormone (rhGH) under the control of a mammary gland specific promoter such that the milk of transgenic females will be an efficient source of protein for purif ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Hyperspectral Assessment & Prediction of Diabetic Foot U

    SBC: Hypermed, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Foot disease complications seriously impact lives of people with Type 1 diabetes. A quantitative method to evaluate efficacy of therapy, or better, to define tissue at risk & prevent initial ulcer formation would be highly beneficial. HYPERMED'S long-term objective is to reduce frequency of foot ulcers & amputation by developing Foot HyperSpectral Imaging (FHSI ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Stratospheric Electrical Environments Applicable To Photovoltaic Arrays On HAA Platforms

    SBC: LIGHTNING TECHNOLOGIES, INC.            Topic: MDA04T008

    The objective of this program is to characterize the upper atmosphere electrical environment so that the effects of this environment on high altitude airships (HAA) and other platforms intending to operate in this environment can be determined, and protection methods developed. This includes transient luminous events (TLEs), such as red sprites and blue jets and their associated electrical propert ...

    STTR Phase II 2005 Department of DefenseMissile Defense Agency
  9. Design and Development of Radiation Hardened ROIC for Multi-color LWIR/VLWIR Focal Plane Arrays

    SBC: MAGNOLIA OPTICAL TECHNOLOGIES, INC.            Topic: MDA05T009

    Radiation Hardened Multi-color infrared (IR) focal planes are required for MDA/SMDC systems applications . Key to meeting these system requirements is to develop multi-color radiation hardened HgCdTe focal plane arrays for LWIR band ( 7-14 microns) and VLWIR band with wavelength of greater than 14 microns with high pixel uniformity, reduced readout noise, improved resolution, and higher temperatur ...

    STTR Phase I 2005 Department of DefenseMissile Defense Agency
  10. Wearable Sternal Skin Conductance Device for Hot Flashes

    SBC: METIS DESIGN CORP            Topic: N/A

    Abstract: The majority of American women transitioning through the menopause will experience hot flashes. However, safe and effective treatments for hot flashes are currently lacking. Investigation of new treatments for hot flashes has been limited by the measurement of hot flashes. Current gold standard physiologic measures of hot flashes have key limitations, including electrode design, monitor ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government